Evaluation of the feasibility of average volume-assured pressure support ventilation in the treatment of acute hypercapnic respiratory failure associated with chronic obstructive pulmonary disease: A pilot study

AVAPS can be used for AHRF associated with COPD. The risk of failed treatment is high for patients with higher baseline APACHE II and nonsignificant improvements in partial pressure of carbon dioxide (arterial) in the first 2 hours of treatment.